Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 6
2007 6
2008 3
2009 9
2010 7
2011 5
2012 6
2013 9
2014 11
2015 16
2016 8
2017 7
2018 4
2019 15
2020 6
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 30612951

105 results
Results by year
Filters applied: . Clear all
Page 1
What Makes a Kinase Promiscuous for Inhibitors?
Hanson SM, Georghiou G, Thakur MK, Miller WT, Rest JS, Chodera JD, Seeliger MA. Hanson SM, et al. Cell Chem Biol. 2019 Mar 21;26(3):390-399.e5. doi: 10.1016/j.chembiol.2018.11.005. Epub 2019 Jan 3. Cell Chem Biol. 2019. PMID: 30612951 Free PMC article.
Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P, Tan L, Chu K, Lee SW, Gray NS, Bullock AN. Canning P, et al. J Mol Biol. 2014 Jun 26;426(13):2457-70. doi: 10.1016/j.jmb.2014.04.014. Epub 2014 Apr 23. J Mol Biol. 2014. PMID: 24768818 Free PMC article.
Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L, Hussain M, Luo J, Duan A, Chen C, Tu Z, Zhang J. Liu L, et al. Chem Biol Drug Des. 2017 Mar;89(3):420-427. doi: 10.1111/cbdd.12863. Epub 2016 Oct 17. Chem Biol Drug Des. 2017. PMID: 27589335
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
Day E, Waters B, Spiegel K, Alnadaf T, Manley PW, Buchdunger E, Walker C, Jarai G. Day E, et al. Eur J Pharmacol. 2008 Dec 3;599(1-3):44-53. doi: 10.1016/j.ejphar.2008.10.014. Epub 2008 Oct 11. Eur J Pharmacol. 2008. PMID: 18938156
Conformational analysis of the DFG-out kinase motif and biochemical profiling of structurally validated type II inhibitors.
Vijayan RS, He P, Modi V, Duong-Ly KC, Ma H, Peterson JR, Dunbrack RL Jr, Levy RM. Vijayan RS, et al. J Med Chem. 2015 Jan 8;58(1):466-79. doi: 10.1021/jm501603h. Epub 2014 Dec 12. J Med Chem. 2015. PMID: 25478866 Free PMC article.
Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.
Kwarcinski FE, Brandvold KR, Phadke S, Beleh OM, Johnson TK, Meagher JL, Seeliger MA, Stuckey JA, Soellner MB. Kwarcinski FE, et al. ACS Chem Biol. 2016 May 20;11(5):1296-304. doi: 10.1021/acschembio.5b01018. Epub 2016 Mar 1. ACS Chem Biol. 2016. PMID: 26895387 Free PMC article.
Structure of the ABL2/ARG kinase in complex with dasatinib.
Ha BH, Simpson MA, Koleske AJ, Boggon TJ. Ha BH, et al. Acta Crystallogr F Struct Biol Commun. 2015 Apr;71(Pt 4):443-8. doi: 10.1107/S2053230X15004793. Epub 2015 Mar 20. Acta Crystallogr F Struct Biol Commun. 2015. PMID: 25849507 Free PMC article.
Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening.
Chen C, Deng J, Yu X, Wu F, Men K, Yang Q, Zhu Y, Liu X, Jiang Q. Chen C, et al. Mol Biosyst. 2016 Apr 26;12(5):1540-51. doi: 10.1039/c5mb00911a. Mol Biosyst. 2016. PMID: 26956955
A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present).
Guo J, Zhang Z, Ding K. Guo J, et al. Expert Opin Ther Pat. 2020 May;30(5):341-350. doi: 10.1080/13543776.2020.1732925. Epub 2020 Feb 26. Expert Opin Ther Pat. 2020. PMID: 32077340 Review.
Perspective on computational and structural aspects of kinase discovery from IPK2014.
Martin E, Knapp S, Engh RA, Moebitz H, Varin T, Roux B, Meiler J, Berdini V, Baumann A, Vieth M. Martin E, et al. Biochim Biophys Acta. 2015 Oct;1854(10 Pt B):1595-604. doi: 10.1016/j.bbapap.2015.03.014. Epub 2015 Apr 7. Biochim Biophys Acta. 2015. PMID: 25861861 Free PMC article. Review.
105 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page